Most stroke patients can't recall when their symptoms started or do not arrive at the hospital in a timely manner, so they cannot be considered for time-dependent therapies such as the clot-busting drug tissue plasminogen activator (tPA), researchers reported in Stroke: Journal of the American Heart Association.